Popik P, Lewin A, Berrang B, Nowak G, Layer R, Skolnick P
Laboratory of Neuroscience, NIDDK, National Institutes of Health, Bethesda, MD 20892-0008, USA.
Eur J Pharmacol. 1995 Nov 30;291(3):221-7. doi: 10.1016/0922-4106(95)90061-6.
[3H]1-Aminocyclopropanecarboxylic acid (ACPC) exhibits high affinity, specific binding to strychnine-insensitive glycine receptors. In extensively washed rat forebrain membranes, the specific binding of [3H]ACPC was optimal at 25 degrees C in the presence of 10 mM MgCl2. Comparable levels of specific [3H]ACPC binding were obtained using centrifugation and filtration for separation of bound from free radioligand. [3H]ACPC labels two sites with Kdl and Bmax1 values of 129 +/- 34 nM and 2.30 +/- 0.37 pmol/mg protein and Kd2 and Bmax2 values of 7.26 +/- 1.69 microM and 20.6 +/- 2.2 pmol/mg protein for the high and low affinity sites, respectively. The Kd of [3H]ACPC (66 nM) estimated under non-equilibrium conditions (koff = 8.91 +/- 0.78 x 10(-3) s-1; kon = 1.35 x 10(-4) nM-1 s-1) was similar to the value obtained for the high affinity site obtained by equilibrium binding. The Kd1 of[3H]ACPC is in good agreement with the previously reported Ki values of ACPC to inhibit the binding of other glycinergic ligands including [3H]glycine, [3H]5,7-dichlorokynurenic acid (5,7-DCKA) and [3H]L-689,560 ((+/-)-4-(trans)-2-carboxy-5,7-dichloro-4- phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline). Moreover, the potencies of a series of glycine site ligands, including glycine. ACPC, 1-aminocyclobutanecarboxylic acid (ACBC), 5,7-DCKA, 7-chlorokynurenic acid (7-CKA), R(+)-3-amino-1-hydroxy-2- pyrrolidine (HA-966) and D-serine, to inhibit [3H]ACPC binding were highly correlated with their potencies to inhibit [3H]glycine and [3H]5,7-DCKA binding (r2 = 0.98-0.51). These results demonstrate that [3H]ACPC is a useful tool for examining the neurochemical and pharmacological properties of strychnine-insensitive glycine receptors.
[3H]1-氨基环丙烷羧酸(ACPC)对士的宁不敏感的甘氨酸受体具有高亲和力和特异性结合。在经过充分洗涤的大鼠前脑细胞膜中,[3H]ACPC的特异性结合在25摄氏度、存在10 mM氯化镁的条件下最为理想。使用离心和过滤法分离结合态与游离放射性配体,可获得相当水平的[3H]ACPC特异性结合。[3H]ACPC标记了两个位点,高亲和力位点的Kdl和Bmax1值分别为129±34 nM和2.30±0.37 pmol/mg蛋白,低亲和力位点的Kd2和Bmax2值分别为7.26±1.69 μM和20.6±2.2 pmol/mg蛋白。在非平衡条件下(koff = 8.91±0.78×10(-3) s-1;kon = 1.35×10(-4) nM-1 s-1)估算的[3H]ACPC的Kd(66 nM)与通过平衡结合获得的高亲和力位点的值相似。[3H]ACPC的Kd1与先前报道的ACPC抑制包括[3H]甘氨酸、[3H]5,7-二氯犬尿氨酸(5,7-DCKA)和[3H]L-689,560((±)-4-(反式)-2-羧基-5,7-二氯-4-苯基氨基羰基氨基-1,2,3,4-四氢喹啉)在内的其他甘氨酸能配体结合的Ki值高度一致。此外,一系列甘氨酸位点配体,包括甘氨酸、ACPC、1-氨基环丁烷羧酸(ACBC)、5,7-DCKA、7-氯犬尿氨酸(7-CKA)、R(+)-3-氨基-1-羟基-2-吡咯烷(HA-966)和D-丝氨酸,抑制[3H]ACPC结合的效力与其抑制[3H]甘氨酸和[3H]5,7-DCKA结合的效力高度相关(r2 = 0.98 - 0.51)。这些结果表明,[3H]ACPC是研究士的宁不敏感的甘氨酸受体的神经化学和药理学特性的有用工具。